Germany · Delayed Price · Currency is EUR Blueprint Medicines Statistics
Total Valuation
FRA:PG4 has a market cap or net worth of EUR 15.19 billion. The enterprise value is 15.83 billion.
| Market Cap | 15.19B |
| Enterprise Value | 15.83B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Jun 2, 2025 |
Share Statistics
| Current Share Class | 223.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -4.27% |
| Shares Change (QoQ) | -1.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 221.70M |
Valuation Ratios
The trailing PE ratio is 15.65 and the forward PE ratio is 8.90.
| PE Ratio | 15.65 |
| Forward PE | 8.90 |
| PS Ratio | 1.18 |
| PB Ratio | 1.50 |
| P/TBV Ratio | 2.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.31 |
| EV / Sales | 1.20 |
| EV / EBITDA | 10.04 |
| EV / EBIT | 12.15 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.66 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | n/a |
| Interest Coverage | 32.68 |
Financial Efficiency
Return on equity (ROE) is 10.39% and return on invested capital (ROIC) is 5.92%.
| Return on Equity (ROE) | 10.39% |
| Return on Assets (ROA) | 0.29% |
| Return on Invested Capital (ROIC) | 5.92% |
| Return on Capital Employed (ROCE) | 0.49% |
| Revenue Per Employee | 654,004 |
| Profits Per Employee | 49,262 |
| Employee Count | 19,700 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:PG4 has paid 123.55 million in taxes.
| Income Tax | 123.55M |
| Effective Tax Rate | 10.74% |
Stock Price Statistics
The stock price has decreased by -8.55% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -8.55% |
| 50-Day Moving Average | 67.59 |
| 200-Day Moving Average | 74.10 |
| Relative Strength Index (RSI) | 45.65 |
| Average Volume (20 Days) | 17 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.10 |
Income Statement
In the last 12 months, FRA:PG4 had revenue of EUR 12.88 billion and earned 970.45 million in profits. Earnings per share was 4.22.
| Revenue | 12.88B |
| Gross Profit | 5.82B |
| Operating Income | 1.27B |
| Pretax Income | 1.15B |
| Net Income | 970.45M |
| EBITDA | 1.48B |
| EBIT | 1.27B |
| Earnings Per Share (EPS) | 4.22 |
Balance Sheet
The company has 3.94 billion in cash and 3.36 billion in debt, giving a net cash position of -245.32 million.
| Cash & Cash Equivalents | 3.94B |
| Total Debt | 3.36B |
| Net Cash | -245.32M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 10.10B |
| Book Value Per Share | 43.55 |
| Working Capital | 10.13B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 45.15%, with operating and profit margins of 9.85% and 7.53%.
| Gross Margin | 45.15% |
| Operating Margin | 9.85% |
| Pretax Margin | 8.93% |
| Profit Margin | 7.53% |
| EBITDA Margin | 11.49% |
| EBIT Margin | 9.85% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.70, which amounts to a dividend yield of 3.88%.
| Dividend Per Share | 2.70 |
| Dividend Yield | 3.88% |
| Dividend Growth (YoY) | 7.81% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 4.27% |
| Shareholder Yield | 8.16% |
| Earnings Yield | 6.39% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |